Huntington's disease (HD) is the most common of nine inherited neurological disorders caused by expanded polyglutamine (polyQ) sequences which confer propensity to self-aggregate and toxicity to their corresponding mutant proteins. It has been postulated that polyQ expression compromises the folding capacity of the cell which might affect other misfolding-prone proteins. a-Synuclein (a-syn) is a small neural-specific protein with propensity to self-aggregate that forms Parkinson's disease (PD) Lewy bodies. Point mutations in a-syn that favor self-aggregation or a-syn gene duplications lead to familial PD, thus indicating that increased a-syn aggregation or levels are sufficient to induce neurodegeneration. Since polyQ inclusions in HD and other polyQ disorders are immunopositive for a-syn, we speculated that a-syn might be recruited as an additional mediator of polyQ toxicity. Here, we confirm in HD postmortem brains and in the R6/1 mouse model of HD the accumulation of a-syn in polyQ inclusions. By isolating the characteristic filaments formed by aggregation-prone proteins, we found that N-terminal mutant huntingtin (N-mutHtt) and a-syn form independent filamentous microaggregates in R6/1 mouse brain as well as in the inducible HD94 mouse model and that N-mutHtt expression increases the load of a-syn filaments. Accordingly, a-syn knockout results in a diminished number of N-mutHtt inclusions in transfected neurons and also in vivo in the brain of HD mice. Finally, a-syn knockout attenuates body weight loss and early motor phenotype of HD mice. This study therefore demonstrates that a-syn is a modifier of polyQ toxicity in vivo and raises the possibility that potential PDrelated therapies aimed to counteract a-syn toxicity might help to slow HD.
INTRODUCTION
Huntington's disease (HD) is the most common of a group of nine inherited devastating neurological disorders caused by CAG triplet-repeat expansions encoding expanded polyglutamine (polyQ) sequences which in turn confer toxicity to their mutated protein products (1) . In HD, this expanded polyQ stretch is located in the N-terminal portion of the huntingtin (Htt) protein (2) . A shared feature of polyQ diseases is the presence of nuclear and cytoplasmic intraneuronal inclusion bodies consisting primarily of aggregation-prone polyQ proteins (3, 4) . The exact mechanism by which expanded polyQ induces neurodegeneration remains unknown. However, it has been suggested that progressive disruption † Present address: Department of Functional Biology, Oviedo University, Oviedo, Spain. * To whom correspondence should be addressed at: Center for Molecular Biology 'Severo Ochoa' (CBMSO), CSIC/UAM, Campus UAM de Cantoblanco, 28049 Madrid, Spain. Tel: +34 911964552/582; Fax: +34 911964420; Email: jjlucas@cbm.uam.es of protein-folding machinery of the cell might explain the commonalities among the neurodegenerative diseases associated with chronic expression of misfolded-and aggregationprone proteins (5) .
a-Synuclein (a-syn) is a small neural-specific protein involved in synaptic function (6,7) with propensity to selfaggregate (8) . a-Syn has been implicated in the etiology of Parkinson's disease (PD) as well as of other neurodegenerative diseases such as multiple system atrophy and Lewy body dementia that share the presence of the characteristic cytoplasmic inclusions termed Lewy bodies (9) . The notion of a-syn as a pathogenic protein arises from, in one hand, the fact that a-syn is the main component of Lewy bodies (9, 10) . On the other hand, point mutations in a-syn that confer a higher propensity for self-aggregation (11, 12) are linked to autosomal dominant forms of PD (13) (14) (15) and duplication and triplication of the a-syn gene lead to a severe and highly penetrant form of PD (16) . Collectively, these findings highlight the ability a-syn to induce or cause neurodegeneration.
It has been reported that a-syn can also be detected in the inclusions of HD patients (17) and of patients of other CAG repeat disorders such as SCA-2 and SCA-3 (18, 19) . The same holds true for the inclusions of the HD89 mouse model of HD (17) . Furthermore, there is evidence that a-syn may act as a modifier of polyQ toxicity in cell and Drosophila models of HD. Namely, a-syn overexpression promotes the aggregation of mutant Htt in PC12 and SKNSH neuroblastoma cells (20, 21) , and neuronal expression of a-syn increases the neurodegeneration of flies expressing exon-1-HttQ120 in the eyes (21) .
Given the well-established pathogenicity of a-syn alterations, the accumulation of a-syn in inclusions of HD mice and patients and the crosstalk between a-syn and mutant Htt in cell and fly HD models, we reasoned that in the context of mutant Htt-induced disease, a-syn might be recruited as an additional mediator of toxicity. Here, we aim to take advantage of mouse genetics to explore this. Accordingly, here, we first confirm the presence of a-syn in cytoplasmic inclusions in the brain of HD patients and extend this finding to the commonly used R6/1 mouse model of HD (22) . Then, by applying a previously reported method (23) to isolate from mouse brain the filaments made of aggregation-prone proteins, here we also explore whether N-terminal mutant Htt (N-mutHtt) and a-syn co-aggregate within the same filamentous microaggregates or whether they instead form independent microaggregates. Finally, to decipher to which extent a-syn might contribute to polyQ-induced toxicity, we here combine R6/1 N-mutHtt mice with a-syn knockout mice (24) and subject them to behavioral and histopathological analysis.
RESULTS

Htt and a-syn co-localize in inclusions of HD patients
In agreement with a previous report (17) , by performing immunohistochemistry with anti-a-syn antibodies on postmortem brain tissue from three grade 4 HD patients and three control subjects, we observed a-syn-positive inclusions in the striatum of patients and extended this finding to the cerebral cortex (Fig. 1A -D) . As shown in Figure 1A , control subjects show a diffuse nerve terminal pattern while HD subjects also show abundant bead-like neuropil inclusions (see solid black arrows in Fig. 1B and C) . Less frequently, a-syn immunoreactivity could also be detected in larger cytoplasmic perinuclear inclusions (see empty arrow in Fig. 1C ) and, very rarely, in small intranuclear inclusions (see thin black arrow in Fig. 1D ). We then performed double immunofluorescence to explore whether a-syn-positive inclusions coincide with Htt-positive inclusions. As shown in Figure 1E -J, a-syn-positive inclusions represent a fraction of the N-mutHtt-positive inclusions in neuropil and dystrophic neurites of HD brains. More precisely, 21% of the Htt-positive inclusions with diameter .2.5 mm and 8% of the Htt-positive inclusions with diameter ,2.5 mm were also positive for a-syn. Furthermore, co-localization with a-syn was also observed when the detection of inclusions in HD brain was performed with an anti-ubiquitin antibody (data not shown).
a-Syn is detected in inclusion bodies of HD mouse models, but forms independent filamentous microaggregates Mouse genetics can be a powerful tool to explore the relevance of a-syn to the pathogenesis of polyQ disease. Accordingly, we decided to test whether a-syn could be detected in inclusions of a commonly used mouse model of HD, namely the R6/1 mouse line. These mice express N-mutHtt with a 116 CAG repeat and they show abundant inclusions in striatal and cortical neurons as well as in other brain regions and develop a progressive HD-like behavioral phenotype (22) . Immunohistochemistry with anti-a-syn antibodies in the brain of R6/1 mice revealed, apart from the widespread nerve terminal staining, the presence of some cytoplasmic or neuropil a-syn-positive inclusions ( Fig. 2A) . This is in agreement with a previous study performed on a mouse model expressing full-length mutant Htt (17) . However, a-syn-positive inclusions in the brain of R6/1 mice were rare in comparison to those found in human HD brain. By performing double-immunofluorescence experiments, we then confirmed that a-syn-positive inclusions in the brain of R6/1 mice are a subset of the Htt-positive neuropil inclusions (Fig. 2B) . Similar results were obtained when the inclusions in R6/1 brains were labeled with an anti-ubiquitin antibody (Fig. 2C) .
As exemplified in Figure 2D and in Supplementary Material, Figure S1 , Htt inclusions in human (25) and mouse (23, 26) brain tissue are ultrastructurally composed of filamentous material. Both N-mutHtt and a-syn are known to aggregate following the classic amyloidogenic cascade from soluble oligomers to filamentous microaggregates (8, (27) (28) (29) (30) . We have previously reported a method for the isolation of such filamentous aggregates from the brain of HD mouse models (23) . In view of the co-localization of N-mutHtt and a-syn in inclusions of R6/1 mice, we wondered whether N-mutHtt and a-syn would be co-aggregated in the same filaments. To explore this, we performed filament preparations from R6/1 mice and subjected them to double-immunoelectron microscopy with anti-N-mutHtt and anti-a-syn antibodies. As shown in Figure 2E and F, the prominent N-mutHtt-positive filaments obtained from R6/1 mice were not immunodecorated with the anti-a-syn antibody. The same result was obtained
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Human Molecular Genetics, 2012, Vol. 21, No. 3 when the filament extraction was performed from brain tissue from a different HD mouse model, namely the inducible HD94 mouse line (Fig. 2G-K) . In both R6/1 and HD94 mice, the a-syn antibody decorated independent and smaller filaments ( Fig. 2F and I-K). To further explore this and to verify the specificity of the a-syn immunodecoration, we performed filament preparations from R6/1 mice and, in parallel, also from wild-type (Wt) and a-syn knockout mice as controls. Interestingly, analysis of the corresponding fractions from Wt mice revealed the presence of the same type of anti-a-syn-decorated filaments (Fig. 2L ), although they were much less abundant than in the R6/1 samples ( Fig. 2M ; see quantification in Fig. 2N ). The specificity of the detection of a-syn-decorated filaments was evidenced by their absence in samples from a-syn knockout mice (Fig. 2N ). In summary, apart from Htt-positive filaments, independent a-syn-positive filaments were observed in samples from R6/1 and HD94 mice. These a-syn-positive filaments were not exclusive of mice expressing mutant Htt, as they can also be observed in Wt mouse samples. However, they are much more abundant in N-mutHtt-expressing mice. Therefore, since a-syn could not be detected in the Htt filaments obtained from HD mouse samples while it was found in different shorter filaments, we conclude that a-syn and N-mutHtt form independent filamentous microaggregates in vivo. Thus, arguing against mixed cross-seeding and suggesting that a-syn and N-mutHtt co-localization in certain inclusions probably reflect the coalescence of independent homomeric microaggregates into the same inclusion bodies.
a-Syn knockout results in the decreased number of Htt inclusions in exon-1-HttQ72 transfected neurons and in R6/1 mice Since it was formerly described that a-syn overexpression promoted Htt aggregation in cellular models of HD (20, 21) , we wondered whether a-syn deficiency would affect in the opposite manner the formation of N-mutHtt inclusions in a cell model. For this, we performed striatal primary cultures from Wt and a-syn knockout (a-Syn2/2) mice and transfected In view of these results, we decided to explore the effect of the lack of a-syn on the load of inclusions in vivo in a mouse model of HD. For this, we produced a small group of R6/1 mice in a-syn knockout background by breeding with mice with a targeted deletion of the a-syn gene (24) and analyzed the number of Htt-positive inclusions at symptomatic ages. Sagittal brain sections of 8-month-old R6/1 and R6/ 1;a-Syn2/2 mice were immunostained with anti-N-terminal-Htt antibody. Htt-positive inclusions were abundant in the striatum of R6/1 mice at this age (Fig. 3D) , and we quantified the number of inclusions with diameter higher than 6 mm. In good agreement with the results from primary transfected neurons, the number of striatal inclusions was lower in R6/1 mice with null a-syn gene dosage (R6/1 versus R6/1;aSyn2/2: 2138.80 + 177.73 versus 1626.53 + 100.80 inclusions/mm 2 ; P ¼ 0.015; Fig. 3E ). However, this decrease in the number of inclusions seems to occur only at late stages of R6/ 1 mice, since it was not apparent in mice analyzed at the age of 5 months (data not shown). In summary, these results indicate that a-syn deficiency results in a diminished number of N-mutHtt inclusions, not only in transfected primary neurons, but also in vivo in the brain of HD transgenic mice.
We then investigated whether the decrease in the number of inclusions observed in the striatum of 8-month-old R6/ 1;a-Syn2/2 mice correlated with changes in the proteolytic machinery of the cell. For this, we performed western blot analysis of proteins indicative of the status of the ubiquitinproteasome system (UPS) or the autophagy in the striatum of 8-month-old R6/1;a-Syn2/2 mice. As shown in Figure 3F , the polyubiquitin smears previously reported to be increased in R6 mice with respect to Wt mice (31) were not significantly affected by the absence of a-syn. Thus, suggesting that the decrease in the number of inclusions observed in R6/1;a-Syn2/2 mice is not due to a different status of the UPS. Regarding autophagy, we measured by western blot the levels of beclin-1 and of Atg5-Atg12 that are proteins involved in early and late stages of autophagy, respectively (Fig. 3G) . Beclin-1 levels in R6/1 mice were unaffected by the knockout of a-syn. However, the level of the Atg5-Atg12 complex shows a tendency to increase in R6/1 mice as the a-syn gene dosage decreases. Thus, suggesting the facilitation of late stages of autophagy by a-syn knockout. This might in part explain the decrease in the number of inclusions observed in R6/1;a-Syn2/2 mice and fits well with the previous report of excess a-syn acting as a negative regulator of autophagy (21) .
Analysis of the effect of a-syn deficiency on the apoptosis and atrophy observed in the striatum of R6/1 mice
We wondered if the decrease in Htt-positive inclusions in R6/1 mice in a-syn knockout background would correlate with changes in other histopathological HD hallmarks, such as cell death or striatal atrophy. To test whether a reduction in the number of inclusions correlates with differences in the rate of striatal apoptotic cell death observed at late stages of disease in R6/1 mice, we performed immunohistochemistry for cleaved caspase-3. Representative images in Figure 4A show the presence of positive cells for cleaved caspase-3 immunostaining in the striatum at 8 months of age. As shown in histogram in Figure 4A , the number of cleaved caspase-3 cells in R6/1; a-Syn2/2 mice presented a tendency to be lower than that in R6/1 mice and comparable with that observed in Wt mice. Similar results were obtained when the rate of apoptosis was analyzed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining (Fig. 4B ). We then analyzed striatal volume in sagittal sections of transgenic mice by using the Cavalieri method. As seen in the histogram in Figure 4C , 8-month-old R6/1 mice presented atrophy within the range of what has been described before (32) , but this was not affected by the gene dosage of a-syn as it was homogeneous within the R6/1, R6/1;a-Syn+/2 and R6/1;a-Syn2/2 groups.
a-Syn deficiency does not affect lifespan but attenuates body weight loss in R6/1 mice
In view of the results concerning inclusion load and incidence of apoptosis obtained in the first group of R6/1 mice in a-syn Figure 2 . a-Syn is detected in Htt inclusion bodies of HD mouse models, but forms independent filamentous microaggregates. (A) a-syn immunohistochemistry in the cortex of R6/1 mice revealed the presence of bead-like neuropil inclusions (solid black arrow) similar to those seen in the human samples. (B) Sections from R6/1 mice subjected to double Htt (green) and a-syn (red) immunofluorescence followed by DAPI blue nuclear counterstaining were analyzed under confocal microscope and revealed the presence of a-syn in a subset of N-mutHtt-positive cytoplasmic inclusions (white arrows). (C) Double a-syn (red) and ubiquitin (green) immunofluorescence experiments were analyzed under a confocal microscope and revealed the presence of a-syn in a subset of neuropil ubiquitin-positive inclusion bodies (white arrow). (D) Ultrastructural transmission electron analysis of an N-mutHtt-stained neuropil inclusion in the striatum of an R6/1 mouse. White arrows indicate the filamentous ultrastructure of the aggregate. (E-M) Immunoelectron microscopy analysis of filamentous aggregates isolated from the forebrain of HD mice. (E-F) N-mutHtt-positive filaments from R6/1 mice (decorated with 5-nm gold particles, black arrows) were not co-decorated for a-syn (detected with 10 nm gold particles). (G-K) Filamentous aggregates isolated from the forebrain of Tet/HD94 mice. As for R6/1 mice, N-mutHtt filaments (in this case decorated with 10-nm gold particles, black arrows) were not co-decorated for a-syn (detected with 5 nm gold particles). In both models, independent a-syn filaments were detected (F and I-K; empty arrows). Fractions from Wt mice showed the same type of anti-a-syn-decorated filaments (L), although R6/1 samples presented a larger number of anti-a-syn-decorated filaments (M) as seen in the histogram in (N) that represents a-syn filament counting in a-Syn2/2, Wt and R6/1 mice. Data are presented as the mean + SEM; * P , 0.05. At least four animals per genotype were used.
Human Molecular Genetics, 2012, Vol. 21, No. 3 499 knockout background, we decided to produce a bigger experimental group of mice for behavioral studies to explore whether a-syn is a relevant player in N-mutHtt-induced disease in vivo. This approach is favored by the fact that a-syn gene knockout mice do not show any obvious behavioral abnormality per se (24) . By combining R6/1 mice and a-syn knockout mice, we therefore obtained mice with any of the six following experimental genotypes: Wt mice (Wt), mice with an heterozygous deletion of the a-syn locus (a-Syn+/2), mice with an homozygous deletion of the a-syn locus (a-Syn2/2), mice that express N-mutHtt with normal a-syn alleles (R6/1), mice that express N-mutHtt with an heterozygous deletion of the a-syn locus (R6/1;a-Syn+/2) and mice that express N-mutHtt with an homozygous deletion of the a-syn locus (R6/1;a-Syn2/2). The breeding protocol starting with R6/1 and a-Syn2/2 mice is shown in Supplementary Material, Figure S2A . Briefly, R6/1 male mice were crossed with a-Syn2/2 female mice. Then, R6/1;a-Syn+/2 and a-Syn+/2 mice from the resulting offspring were intercrossed to obtain the six mentioned experimental genotypes (Supplementary Material, Fig. S2B ). This way, a total of 264 mice were generated that showed a normal Mendelian segregation among the six possible genotypes, as confirmed by x 2 analysis (Supplementary Material, Fig. S2C ; P ¼ 0.414), thus indicating no embryonic lethality associated with any of the possible genotypes.
As a global indicator of the potential effect of a-syn gene dosage on polyQ-induced disease in vivo, life expectancy was monitored in these mice. Figure 5A shows the cumulative survival for the six genotypes calculated by means of the Kaplan -Meier analysis. Obviously, as reported previously, significant differences in lifespan were observed between non-N-mutHtt-expressing and N-mutHtt-expressing mice (P Log-rank ≤ 0.0005, P Breslow ≤ 0.0005, P Tarone-Ware ≤ 0.0005). However, there were no significant differences among N-mutHtt-expressing mice regarding survival. Lifespan for R6/1 mice was 297.37 + 10.28 days, for R6/1;a-Syn+/2 mice 289.00 + 9.66 days and for R6/ 1;a-Syn2/2 mice 289.35 + 10.26 days.
As an additional global indicator of the potential effect of a-syn gene dosage on polyQ-induced disease in vivo body weight was monitored along the whole study. As extensively reported (22,33 -35) , R6/1 mice failed to show the progressive weight gain that Wt mice experience from 2.5 to 8 months of age. Figure 5B shows body weight evolution along time of the six genotypes expressed as percentage with respect to Wt mice. N-mutHtt-expressing mice presented differences with respect to Wt mice since early ages in the study. However, these differences did not appear at the same time in the three R6/1 groups. Thus, whereas R6/1 and R6/1;a-Syn+/2 mice showed a decrease in body weight with respect to Wt mice at 2.5 months (Wt versus R6/1: 100 + 1.51 versus 82.41 + 2.78%, P ¼ 0.019; Wt versus R6/1;a-Syn+/2: 100 + 1.51 versus 90.74 + 1.54%, P ¼ 0.009), in the case of R6/1;a-Syn2/2 mice, the difference was not seen until the age of 4 months (Wt versus R6/1;a-Syn2/2: 100 + 4.77 versus 81.64 + 3.04%, P ¼ 0.023). In fact, as shown in Figure 5C and D, body weight of R6/1;a-Syn2/2 mice was almost 20% higher than that of R6/1 at 2.5 and 4 months (2.5 months: P ¼ 0.004; 4 months: P ≤ 0.0005) and milder but significant differences were maintained along the whole study. In summary, a-syn knockout delays body weight deficit in R6/1 from 2.5 to 4 months of age and keeps attenuating it up to more advanced stages of disease progression.
a-Syn deficiency attenuates early motor impairment in R6/1 mice
We then assessed the potential role of a-syn in mediating the motor phenotype of R6/1 mice. Scoring of clasping in the tail suspension test is a common assay to evaluate involuntary movements in HD mouse models (22, 36) . Accordingly, mice were recorded for 30 s and the videos were stopped every 2 s to score each mouse and we analyzed the cumulative percentage of mice showing clasping. Since no gender differences were detected, male and female mice were grouped together for the analysis of genotype effect (Fig. 6A) . Only N-mutHtt-expressing mice showed a clasping phenotype along the whole study starting at the age of 4 months. At this age, 60% of the R6/1 mice presented a clasping phenotype. In contrast, only 33.3 and 28.5% of R6/1;a-Syn+/2 and R6/1;a-Syn2/2 mice, respectively, showed clasping (P ≤ 0.005). However, this beneficial effect of a-syn deficiency occurs only at initial stages of disease progression as the three R6/1 groups presented a similar percentage of a clasping phenotype at 6 and 8 months of age.
Other common motor test widely used to examine HD mouse models is rotarod. It has been recently described that accelerating rotarod is more sensitive than fixed-speed rotarod for detecting early motor deficits in R6 mice (37) . Thus, mice were analyzed on the rotarod apparatus set to accelerate from 4 to 40 rpm along a 5-min period and mice were tested in four trials with 1 h inter-trial periods. Mice were examined at the age of 2.5, 4, 6 and 8 months. Since no gender differences were detected, male and female mice were grouped together for the analysis of genotype effect. As expected, N-mutHtt-expressing mice showed a deficit in this motor coordination task (Fig. 6B) . This deficit started at the age of 4 months and then showed a progressive worsening until the last time point of the study, at 8 months. Interestingly, analysis of the percentage of mice on rod at the highest speeds of the accelerating paradigm (Fig. 6C) revealed that R6/1;a-Syn+/2 and R6/1;a-Syn2/2 mice perform better than R6/1 mice at 4 and 6 months of age (4 months, 36 rpm: P ¼ 0.048; 4 months, 40 rpm: P ¼ 0.005; 6 months, 32 rpm: P ¼ 0.003; 6 months, 36 and 40 rpm: P ¼ 0.001). In conclusion, analysis of a clasping phenotype and rotarod performance revealed that a-syn deficiency attenuates the motor phenotype of R6/1 mice at early stages of disease progression.
DISCUSSION
Increased levels or aggregation of a-syn are sufficient to induce neurodegeneration as evidenced by the facts that duplication or triplication of the a-syn gene or point mutations that confer a higher propensity for a-syn self-aggregation leads to severe forms of PD (13, 14, 16) . Here, we have confirmed in HD postmortem brains and in the R6/1 mouse model of HD the accumulation of a-syn in polyQ inclusions that had been previously reported in patients of HD and other CAG repeat disorders (17 -19) . Furthermore, based on a method that we previously established to isolate filamentous microaggregates like those that form inclusion bodies (23), we here demonstrate that N-mutHtt and a-syn form independent homomeric filaments and that N-mutHtt expression increases the load of a-syn filamentous microaggregates. Thus, arguing against mixed cross-seeding and rather fitting with the suggested N-mutHtt-induced progressive disruption of cellular protein folding (5, 38) , leading to homomeric aggregation of misfolding-prone proteins and subsequent coalescence of independent homomeric microaggregates into the same inclusion bodies. Finally, to explore whether a-syn is a modifier of polyQ-induced toxicity in vivo, we took advantage of mouse genetics and found that a-syn knockout results in a diminished number of N-mutHtt inclusions in transfected mouse neurons and also in vivo in the brain of HD transgenic mice. Most importantly, a-syn knockout also results in the attenuation of the body weight loss and of the early motor phenotype of HD mice. Since a-syn knockout per se does not induce a clear neurological phenotype in mice (24) , the combination of an HD mouse model and a-syn knockout mice represents a powerful approach to decipher whether polyQ-induced alterations in a-syn proteostasis might contribute to HD pathogenesis. The fact that a-syn deficiency attenuates body weight loss and early motor dysfunction of R6/1 mice strongly indicates that a-syn acts as an additional mediator of toxicity in early stages of polyQ-induced disease in vivo. Also, the reported effect of a-syn deficiency on the load of inclusion bodies suggests that competition for the protein-folding machinery and/ or interfering with protein degrading systems such as autophagy and the UPS might account for the recruitment of a-syn as an additional mediator of polyQ toxicity. Collectively, out data demonstrate that a-syn is a modifier of polyQ-induced toxicity in vivo and we will discuss below the possible underlying mechanisms.
Regarding the possible competition for the protein-folding machinery, it has been shown that expression of expanded polyQ in various Caenorhabditis elegans strains expressing temperature-sensitive mutants of structurally and functionally unrelated proteins results, at permissive temperatures, in the induction of the phenotype associated with the aberrant conformation (5). Thus, suggesting that polyQ expression induces a progressive disruption of the folding capacity of the cell. Since there are many marginally stable or foldingdefective proteins in the cell that may be affected by such disruption in the folding machinery, this has been postulated as a feedback mechanism that might explain the similarities among the many conformational neurodegenerative diseases (5). Our study suggests that a-syn may be one of such foldingdefective proteins affected by N-mutHtt expression in vivo. N-mutHtt-induced alterations in a-syn conformation and aggregation could then significantly contribute to disease progression in the early stages but, as additional conformationally unstable proteins are engaged, the contribution of a-syn might become marginal, thus explaining why a-syn knockout does not significantly influence lifespan and the late motor phenotype of R6/1 mice.
Regarding protein degradation, a-syn has been reported to be degraded mainly through autophagy (39) . However, it has also been reported that proteasome inhibitor administration to cell models of polyQ disease results in increased formation of inclusion bodies and that these are immunopositive for a-syn (40), and it is well documented that UPS and autophagy alterations affect each other, probably as compensatory mechanisms (41) .
Whether the UPS is impaired in polyQ disease has been a matter of debate. On one hand, impaired proteasome activity was reported in polyQ cell models (42, 43) and we have also shown that filamentous microaggregates of N-mutHtt are able to impair 26S proteasome activity in vitro (44) . On the contrary, proteasome activity was not diminished in brain homogenates of HD mice (45) and no global impairment of the UPS is detected under the steady-state expression of N-mutHtt in adult HD mice (31, 46, 47) despite the accumulation of high molecular weight polyubiquitin conjugates (31) . However, UPS impairment has been confirmed in vivo in mouse models but only locally at the synapse (48) or transiently upon acute N-mutHtt expression before inclusion formation takes place (47) . In fact, such transient nature of polyQ-induced UPS impairment might also explain the transient beneficial effect of a-syn knockout in early disease progression of R6/1 mice. a-Syn-mediated toxicity might occur only transiently due to a recovery of the UPS upon efficient inclusion body formation. Regarding possible differences in the status of the UPS to account for the decrease in the number of inclusions observed in the striatum of 8-month-old R6/1;a-Syn2/2 mice, here, the reported data of polyubiquitin smears not being significantly affected by the absence of a-syn argues against this possibility.
Regarding autophagy, here, we show that the level of the Atg5 -Atg12 complex shows a tendency to increase in R6/1 mice as the a-syn gene dosage decreases. This suggests a possible increase in autophagy that might in part explain the decrease in the number of inclusions observed in 8-month-old R6/1;aSyn2/2 mice and fits with the recent reports of a-syn as a negative regulator of autophagy. On one hand, excess a-syn has been shown to impair macroautophagy via Rab1a inhibition (21) . Consequently, excess a-syn results in an increased load of aggregates in cell models expressing exon-1-HttQ74 and in increased neurodegeneration in flies expressing exon-1-HttQ120 in the eyes (21) . More recently, a positive feedback loop model of excess a-syn inducing lysosomal dysfunction has been proposed (49) . More precisely, in the context of the clinical link between the lysosomal storage disorder Gaucher's disease (GD) and PD, Mazulli et al. reported that GD-linked mutations in glucocerebrosidase (GCase) result in an increased level of glucosylceramide that facilitate the formation of a-syn oligomers. This, in turn, hampers vesicle transport between endoplasmic reticulum and the Golgi apparatus, the main trafficking route for GCase to reach the lysosome. Therefore, it is possible that N-mutHtt-induced alterations in a-syn conformation and aggregation might contribute to the in vivo progression of HD in part by affecting lysosomal function and autophagy.
We are not the first to describe a-syn accumulation in neurodegenerative diseases other than the typical synucleinopathies such as PD or Lewy body disease. As already mentioned, this had been described for various PolyQ diseases (17) (18) (19) and, interestingly, also for Alzheimer's disease (AD). Since AD patients also show the typical tau and Ab depositions, this disease has been considered a 'triple brain (14) . Data are expressed as the percentage over the total genotype population; * P , 0.05; * * P , 0.01; * * * P , 0.001.
amyloidosis' (50) and there are many in vivo studies supporting that a-syn affects Ab and tau pathology. As examples of a-syn and tau interactions, a patient with the a-synA53T mutation exhibited neurofibrillar tangle pathology in addition to Lewy bodies (51) and a small percentage of the M83 a-synA53T transgenic mouse line also exhibits tau inclusions (52) . As an example of a-syn and Ab interactions, doubletransgenic a-syn/amyloid precursor protein mice exhibit increased a-syn deposition versus single-transgenic mice (53) . It had also been hypothesized that Ab, tau and a-syn promote the aggregation of one another probably through a cross-seeding mechanism (52) . In fact, in vitro aggregation studies revealed that co-incubation of a-syn and tau promotes their polymerization (52) . However, in good agreement with our results showing the isolation of independent a-syn and N-mutHtt filaments from the brain of R6/1 mice, analysis of filaments formed in vitro by co-incubation of tau and a-syn also revealed that they were essentially independent homopolymers (52) . Heteromeric cross-seeding appears to occur only among proteins with equivalent molecular structures due to sequence similarity. Accordingly, N-mutHtt has been reported to cross-seed and form mixed fibrillation only with Q/N-rich proteins such as the RNA-binding protein TIA-1 (54) and the NM domains of Sup35p (55) . Since a-syn does not share such a sequence similarity with tau or with N-mutHtt, it is not surprising that Giasson and co-workers and we observed independent homomeric filaments. Therefore, the coincidence of N-mutHtt and a-syn in inclusions is most likely the consequence of coalescence of the specific filaments in bigger aggregates similar to what has been described in cellular models expressing polyQ fusion proteins (38) .
In summary, here, we have confirmed in postmortem HD brains and in the R6/1 mouse model the accumulation of a-syn in polyQ inclusions that was previously reported in the brains of patients of various CAG repeat disorders. Furthermore, we found that N-mutHtt and a-syn form independent homomeric filaments. Finally to elucidate if a-syn is recruited as an additional player in pathogenicity triggered by N-mutHtt, we brought R6/1 mice to a-syn deficient backgrounds. Since a-syn deficiency results in the improvement of body weight and of motor tasks in early symptomatic mice, we conclude that a-syn is a modifier of polyQ toxicity in vivo. The observed effect on a-syn knockout on N-mutHtt inclusion formation suggests that competition for proteinfolding and degradation machineries may underlie the observed beneficial effects of a-syn knockout. Finally, our study also raises the possibility that any PD-related new experimental approach aimed to counteract a-syn toxicity might also be used to slow HD progression.
MATERIALS AND METHODS
Human samples
Brain specimens used in this study were removed at autopsy from three HD and three age-matched controls following the protocols of nervous tissue donation approved by the local Ethical Committees of the Barcelona and Bellvitge brain banks. The postmortem delay in tissue processing was between 4 and 15 h in both groups. The neuropathological examination in HD cases revealed a diagnosis of HD grade 4 following the criteria of Vonsattel (56) , revised in Vonsattel and DiFiglia (57) .
Animals
R6/1 mice transgenic for the human exon-1-Htt gene, in the B6CBAF1/J background (22) , were used. Special attention was paid in order not to use B6CBAF1 mice from Harlan at any production step, since C57B6 mice from Harlan are known to be natural mutants lacking a-syn (58). a-Syn knockout (a-Syn2/2) mice (B6; 129X1-Snca tm1Rosl /J) (24) were purchased from Jackson Laboratories. To obtain R6/1 mice in a-syn+/2 and a-syn2/2 backgrounds, male R6/1 mice (R6/1) were crossed with a-Syn2/2 females. From the offspring, a second cross was set with R6/1;a-Syn+/2 male mice and a-Syn+/2 females, to achieve six different genotypes which covered from null to two a-syn gene doses and the presence or the absence of the R6/1 transgene (Supplementary Material, Fig. S2 ).
Mice were bred at Centro de Biología Molecular 'Severo Ochoa' (Madrid, Spain). Four or five mice were housed per cage with food and water ad libitum. Mice were maintained in a temperature-controlled environment on a 12 h light/dark cycle with lights onset at 7:30 AM. All experiments were performed in accordance with institutional guidelines approved by the ethical committee of Consejo Superior de Investigaciones Científicas (CSIC).
Immunohistochemistry and immunofluorescence in human tissue
Immunohistochemistry. Human cryoprotected sections, 30 mm thick, were pre-treated in boiling epitope unmasking solution (SSC, 150 mM NaCl and 15 mM sodium citrate, pH 7.0) for 8 min to unmask aggregated a-syn. After cooling the slices in distilled water, sections were washed twice in phosphate buffered saline (PBS) and endogenous peroxidase activity was inactivated with H 2 O 2 in methanol for 30 min at room temperature and then the sections were incubated in blocking solution [1% bovine serum albumin (BSA), 0.5% fetal bovine serum and 0.2% Triton X-100 in PBS] for 1 h at room temperature. Then, sections were incubated with mouse anti-a-Syn primary antibody (Novocastra) overnight at 48C. After washing with PBS, sections were incubated with the secondary components of the Elite Vectastain kit (Vector Laboratories). Diaminobenzidine (Sigma) was used as a peroxidase substrate and, once dried, sections were cover slipped with PermaFluor Aqueous Monting Medium (Thermo Scientific).
Immunofluorescence. Human paraffin sections, 4 mm thick, were pre-treated with 5% formic acid for 3 min to unmask aggregated a-syn and then incubated in 10% fetal bovine serum diluted in PBS to avoid non-specific binding. Sections were incubated overnight at 48C with a combination of two primary antibodies: anti-a-syn (amino acids 111 -131, Chemicon) and anti-N-terminal Htt (MAB5374, Millipore) or anti-a-syn (C-20)-R (Santa Cruz Biotechnology) and anti-N-terminal Htt (MAB5374). After washing with PBS, the sections were incubated with secondary antibodies: anti- 
Immunohistochemistry and immunofluorescence in mouse tissue
In each experiment, all mice were processed in parallel and samples have been treated identically. Briefly, mice were sacrificed by CO 2 , and brains were removed and halved sagittally immediately after decapitation. Left hemispheres were processed for histology, fixed with 4% paraformaldehyde (PFA) in Sorensen's phosphate buffer overnight at 48C, and then were immersed in 30% sucrose in PBS for 48 h for cryoprotection. Next, samples were frozen in OCT (Optimal Cutting Temperature, Tissue-Tek) and stored at 2808C until use. Sagittal sections (30 mm) were cut on a CM 1950 Ag Protect freezing microtome (Leica) and placed and stored in a solution containing 30% glycerol and 30% ethyleneglycol in 0.02 M monobasic phosphate buffer at pH 7.2 at 2208C. To detect a-syn aggregates by immunohistochemistry or by immunofluorescence, a previous epitope unmasking step was performed as above described for the human tissue staining.
Immunohistochemistry. For a-syn detection in mouse tissue sagittal sections were pre-treated by boiling in epitope unmasking solution (SSC) for 8 min. After cooling the slices in distilled water, sections were pretreated for 30 min in 1% H 2 O 2 /PBS, followed by 1 h in blocking solution and incubated overnight with primary antibodies: mouse anti-a-Syn-1 (BD Transduction Laboratories), mouse anti-N-terminal Htt (MAB5374, Millipore) and rabbit anti-cleaved caspase-3 (Asp175) (Cell Signaling). Finally, the peroxidase activity was developed with the Elite Vectastain kit (Vector Laboratories) using diaminobenzidine (Sigma). Sections were cover slipped with PermaFluor Aqueous Monting Medium (Thermo Scientific). Digital images were capture with an Olympus Bx 51 microscope coupled to a Color View IIIu digital camera with 20× objective lens with the help of the Olympus Soft Imaging System.
Immunofluroscence. After the unmasking step in SSC, sagittal sections were incubated with 1% Triton X-100 in PBS and followed by blocking solution (1% BSA and 0.1% Triton X-100 in PBS). Sections were further incubated with two combinations of primary antibodies: mouse anti-N-terminal Htt (MAB5374, Millipore) and rabbit anti-a-Syn (C-20)-R (Santa Cruz Biotechnology) or with rabbit anti-ubiquitin (Dako) and mouse anti-a-Syn [4D6] (Abcam) at 48C overnight. As secondary antibodies, anti-mouse Oregon Green 488 and anti-rabbit Texas Red-X 587 or anti-rabbit Oregon Green 488 and anti-mouse Texas Red-X 587 (Invitrogen) were used. Nuclei were stained with DAPI (Calbiochem). Once air-dried in darkness, sections were cover slipped with PermaFluor Aqueous Monting Medium (Thermo Scientific). Images were acquired with the vertical Axio Imager.M2 microscope using the LSM510 software (Carl Zeiss) with a 100×, 1.4 numerical aperture oil immersion objective or with the vertical Axioskop2 plus microscope using the Metavue 5.07 software (Universal Imaging) with a 63×, 1.4 numerical aperture oil immersion objective. 
Htt inclusions counting in mouse samples
TUNEL assay
For each mouse, five regularly spaced sagittal sections spanning the whole striatum were processed according to the In Situ Cell Death Detection Kit protocol (POD, Roche). All analyses were performed in a blinded manner, and results were presented as the number of TUNEL-positive cells per 30-mm section.
Striatal volume analysis
Striatal volume was determined in every sixth sagittal section by using the Cavalieri method. Digital images were captured at a 2.5× magnification (Canon EOS 450D digital camera). The striatal area from 15 sections for each animal was calculated by means of the ImageJ software. Considering a separation of 180 mm between each section, total striatal volume of each mouse was calculated. Data are represented as the mean + SEM.
Western blot
Mouse brains were quickly dissected on an ice-cold plate. Extracts for western blot analysis were prepared by homogenizing the striatum in ice-cold extraction buffer consisting of 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.4, 100 mM NaCl, 20 mM NaF, 1% Triton X-100, 1 mM sodium orthovanadate, 5 mM EDTA and protease inhibitors (2 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, 10 mg/ml leupeptin and 10 mg/ml pepstatin). The samples were centrifuged at 15 000g for 20 min at 48C. The resulting supernatant was collected and protein content was determined by Bradford. Five micrograms of total protein was electrophoresed on 10% sodium dodecyl sulfate -polyacrylamide gel and transferred to a nitrocellulose membrane. The following primary antibodies were used: anti-ubiquitin (clone FK2, Millipore), anti-beclin1 (Santa Cruz Biotechnology), anti-Atg5 (Millipore) and anti-b-actin (Sigma). The blots were incubated with the primary antibody at 48C overnight in 5% non-fat dry milk followed by secondary polyclonal anti-mouse or anti-rabbit immunoglobulins conjugated with horseradish peroxidase (DAKO Cytomation) and ECL detection (Perkin Elmer).
Tissue processing for electron microscopy
For electron microscopy, immunostained vibratome sections were processed as described previously (59) . Briefly, the sections were post-fixed in 2% OsO 4 for 1 h, dehydrated, embedded in Araldite and flat-mounted in Formvar-coated slides, using plastic cover slips. After polymerization, selected areas were photographed, trimmed, re-embedded in Araldite and resectioned at 1 mm. These semi-thin sections were rephotographed and resectioned in ultrathin sections. The ultrathin sections were observed in a Jeol electron microscope, without heavy metal staining to avoid artifactual precipitates.
Immunoelectron microscopy of purified filamentous microaggregates
Isolation of filamentous microaggregates from mouse brain tissue was performed as described previously (23) . Briefly, forebrains were homogenized in buffer 1 (10 mM Tris, 1 mM EGTA, 0.8 M NaCl, 10% sucrose, 0.1% Triton X-100 and protease inhibitors) in a glass homogenizer. After centrifugation at 2988g (Sorvall SS34 rotor, Thermo Scientific) for 20 min, the supernatant S1 was saved and pellet P1 was homogenized in buffer 1 and centrifuged again. The supernatants S1 and S2 were combined, adjusted to 1% (w/v) N-lauroylsarcosine and 1% (v/v) b-mercaptoethanol and incubated for 2 h at room temperature. After centrifugation at 134 877g (TLA-100.3 rotor, Beckman Coulter) for 45 min, filament-containing pellets were homogenized in buffer 2 (10 mM Tris, 1 mM EGTA, 0.8 M NaCl, 10% sucrose and protease inhibitors), layered over a discontinuous sucrose gradient consisting of 50% sucrose and 20% sucrose in buffer 3 (10 mM Tris, 1 mM EGTA and 0.8 M NaCl) and centrifuged for 2 h at 217 290g (SW40 rotor, Beckman Coulter). The filament-containing fraction was collected from the 20-50% interface and stored at 2708C until use. Double-immunoelectron microscopy was performed after the adsorption of the filament-containing fraction to electron microscopy carbon-coated grids. Samples were incubated with anti-N-terminal Htt (MAB5374, Millipore), anti-N-terminal Htt (CAG53b; amino acids 1-118 with a 51 polyQ stretch, a kind gift from Dr Wanker, Berlin, Germany) and anti-a-syn (C-20; Santa Cruz Biotechnologies). Grids were then incubated with secondary goldconjugated antibodies (Sigma). Finally, the samples were stained with 2% uranyl acetate. Transmission electron microscopy was performed in a Jeol (Peabody, MA) model 1200EX electron microscope operated at 100 kV. For a-syn filament counting, seven grids for each condition were analyzed by counting four fields per grid at 25 000× magnification.
Primary neuron culture, transfection, immunofluorescence and inclusion counting
Primary neuronal cultures were prepared according to modifications of established procedures (60) . Briefly, Wt or a-Syn knockout pups were sacrificed at postnatal day 0. Striatal tissue was dissected and dissociated with the Papain Dissociation System (Worthington). Striatal neurons were maintained in Neurobasal medium (Invitrogen) supplemented with 1% sodium pyruvate, 0.5 mM glutamine, 10% v/v horse serum and 1% penicillin/streptomycin and grown on 3 mg/ml laminin (Sigma) and 10 mg/ml poly-L-lysine-coated chamber slides (m-Slide for a high-quality microscopy, Ibidi). After 2 h of incubation, the culture medium was replaced with Neurobasal medium supplemented with 1% sodium pyruvate, 0.5 mM glutamine and 2% B27. Cells were maintained in 95% air/5% CO 2 in a humidified incubator at 378C.
Transfection was performed 1 day after plating. Htt constructs comprised pEGFP-1 with the N-terminal fragment of Htt with 17 or 72 CAG repeats fused to the EGFP (kindly provided by Drs Finkbeiner and Arrasate). Cells were transiently transfected with 1 mg of plasmid DNA and 3 ml of Lipofectamine (Invitrogen) in 100 ml of Neurobasal medium. The mixture was carefully (drop by drop) directly added to the medium (without antibiotics) and incubated for 2 h in 95% air/5% CO 2 in a humidified incubator at 378C. Next, cells were washed three times with PBS and added to Neurobasal medium supplemented with 1% sodium pyruvate, 0.5 mM glutamine, 2% B27 and 1% penicillin/streptomycin. Transfection efficiency was controlled by counting the number of transfected neurons corrected by the total number of neurons (a minimum of 300 cells were analyzed per experimental condition). Transfection efficiency was between 3 and 6% across all experiments.
After 16 h of transfection, cells were fixed with 2% PFA in Sorensen's phosphate buffer for 10 min and washed twice with PBS prior fixation in 4% PFA for 10 min. Then, slices were washed again in PBS and nuclei were stained with DAPI (Calbiochem). Once air-dried in darkness, sections were cover slipped with Fluoresave (Calbiochem).
For inclusion counting, 60 fields from a total of eight slices for each condition were counted at a magnification of 63× in Axioskop 2 plus upright microscope (Zeiss) coupled to a Coolsnap FX color camera (Roper Scientific).
Behavioral tests
Survival. One hundred and thirty-four mice were kept for survival. Life expectancy study was finished at day 700, 350 days after the last N-mutHtt-expressing mouse died spontaneously. Results are represented as the Kaplan -Meier curves.
Body weight. Starting at 2.5 months, mice were weighed once a month. Results are represented as the mean + SEM.
Behavioral testing started at 2.5 months and finished at 8 months, when transgenic mice presented several difficulties to perform the tasks. The number of mice used in this round of behavioral test was 91.
Clasping. Mice were suspended by the tail 20 cm above the cage for 30 s and recorded. Every 2 s, the video was stopped and the number of limbs clasping was observed. For the cumulative percentage of mice clasping, the first time the animal clasped was scored as positive and was not considered again. Results are represented as the cumulative percentage of mice with a clasping phenotype.
Rotarod. Motor coordination was tested on an accelerating rotarod apparatus (Ugo Basile). Initially, each mouse was trained for 2 days. In the first day, mice performed four trials (1 h intervals) at a fixed speed (4 rpm) for 60 s. In the second day, mice performed also four trials at a fixed speed at 8 rpm for 60 s. The third day, rotarod was set to accelerate from 4 to 40 rpm over 5 min and mice were tested four times (1 h intervals). During accelerating trials, the latency of each mouse to fall from the rotarod was measured. Results are represented as the mean + SEM of the latencies to fall in the four trials and as the percentage of mice on a rod at the highest speeds.
Statistical analysis
The normality of the data was tested by means of the ShapiroWilk test. In view of the results, for non-parametric data, the following tests were applied for comparison of differences in several variables among genotypes: the Mann -Whitney U-test to compare a-syn filaments counting; the KruskalWallis H test followed by the Mann -Whitney U-test were used in the case of cleaved caspase-3, TUNEL, striatal volume, body weight and mean latency on rod studies. For parametric data, differences in several variables among genotypes were analyzed by the following tests: independent two-sample Student's t-test was applied for inclusion counting in cell cultures and one-way analysis of variance followed by the Bonferroni post hoc test were used for striatal inclusion counting in R6/ 1 mice. Genotype frequencies, percentage of clasping mice and percentage of mice on rotarod were analyzed by means of x 2 test. Cumulative survival was analyzed by the logrank, Breslow and Tarone -Ware tests. A critical value for the significance of P , 0.05 was used throughout the study. The SPSS 17.0 software was used for statistical analysis.
